Concord Medical Services Holdings Limited (CCM) Stock Score, Valuation & Financial Research
Concord Medical Services Holdings Limited is in the Healthcare sector and Medical - Care Facilities industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 23/100.
Quick answer for CCM
Concord Medical Services Holdings Limited currently has a Wall Street Score of 23/100. The stored market price is $3.95. Its financial score is 19/100. Its valuation score is 0/100. These figures are a research snapshot, not a buy or sell recommendation.
What Concord Medical Services Holdings Limited does
Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People’s Republic of China. It operates in two segments, Network and Hospital. The company’s services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services. Its other treatments and diagnostic services comprise positron emission tomography-computed tomography and magnetic resonance imaging scanners. In addition, the company provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel. Further, it offers radiotherapy and diagnostic equipment leasing, managem
CCM financial snapshot
- Wall Street Score:
- 23/100
- Current price:
- $3.95
- Market capitalization:
- $575K
- Revenue:
- $87.2M
- Net income:
- $-18.5M
- Free cash flow:
- $-43.7M
- Cash:
- $44.3M
- Total debt:
- $541.3M
- EPS:
- -127.58
- Financial score:
- 19/100
- Valuation score:
- 0/100
- Revenue score:
- 39/100
What stands out
- Reported year-over-year revenue growth is +0.3%.
- Free cash flow is $-43.7M, showing cash burn in the current stored period.
- The balance sheet shows $44.3M of cash versus $541.3M of total debt, so leverage deserves attention.
- The current research record carries a severe debt stress warning, which should be reviewed alongside the score.
What the numbers mean
Its current valuation score is 0/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 19/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-09-14.
How to research CCM
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.